Godavari Drugs Limited (GODAVARI.BO)
INR 117.35
(0.17%)
INR 117.35
(0.17%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Revenue | 1.56 Billion | 1.59 Billion | 1.61 Billion | 1.22 Billion | 956.97 Million | 835.44 Million |
| Cost of Revenue | 1.2 Billion | 1.28 Billion | 1.3 Billion | 965.88 Million | 766.7 Million | 649.1 Million |
| Gross Profit | 359.01 Million | 315.67 Million | 306.5 Million | 260.82 Million | 190.26 Million | 186.33 Million |
| Operating Expenses | 359.01 Million | 216.52 Million | 208.12 Million | 174.64 Million | 141.04 Million | 142.31 Million |
| Selling, General and Administrative Expenses | 5.18 Million | 3.42 Million | 5.64 Million | 4.95 Million | 3.96 Million | 2.4 Million |
| Research and Development Expenses | 3.24 Million | 2.81 Million | 2.88 Million | 2.65 Million | 2.48 Million | 3.12 Million |
| Other Expenses | 350.57 Million | 3.93 Million | 1.55 Million | 1.43 Million | 1.61 Million | 946.48 Thousand |
| Cost and Expenses | 1.27 Billion | 1.49 Billion | 1.51 Billion | 1.14 Billion | 907.74 Million | 791.42 Million |
| Operating Income | -67.67 Million | 102.44 Million | 96.58 Million | 86.04 Million | 48.72 Million | 43.9 Million |
| Interest Expense | 49.15 Million | 28.65 Million | 16.79 Million | 21.39 Million | 19.47 Million | 21.35 Million |
| Income Tax Expense | 13.72 Million | 11.48 Million | 17.75 Million | 15.78 Million | 2.88 Million | 5.37 Million |
| Earnings before Tax | 69.21 Million | 49.34 Million | 70.2 Million | 57.06 Million | 22.88 Million | 17.45 Million |
| Net Income | 55.48 Million | 37.85 Million | 52.45 Million | 41.28 Million | 20 Million | 12.08 Million |
| Earnings Per Share Basic | 7.37 | 5.03 | 6.97 | 5.48 | 2.66 | 1.60 |
| Earnings Per Share Diluted | 7.37 | 5.03 | 6.97 | 5.48 | 2.66 | 1.60 |
| Weighted Average Shares Outstanding | 7.52 Million | 7.53 Million | 7.53 Million | 7.53 Million | 7.53 Million | 7.53 Million |
| Weighted Average Shares Outstanding (Diluted) | 7.52 Million | 7.53 Million | 7.53 Million | 7.53 Million | 7.53 Million | 7.55 Million |
| Gross Margin | 0.23 | 0.20 | 0.19 | 0.21 | 0.20 | 0.22 |
| EBIT Margin | 0.09 | 0.06 | 0.06 | 0.07 | 0.06 | 0.06 |
| Profit Margin | 0.04 | 0.02 | 0.03 | 0.03 | 0.02 | 0.01 |
| EBITDA | 134.62 Million | 118.58 Million | 116.9 Million | 102.37 Million | 60.91 Million | 55.83 Million |
| Earnings Before Tax Margin | -0.04 | 0.06 | 0.06 | 0.07 | 0.05 | 0.05 |
| Breakdown | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 | 2023 Q1 |
|---|---|---|---|---|---|---|
| Revenue | 322.07 Million | 386.4 Million | 1.56 Billion | 431.1 Million | 395.42 Million | 354.18 Million |
| Cost of Revenue | 252.21 Million | 296.4 Million | 1.27 Billion | 360.94 Million | 307.56 Million | 280.66 Million |
| Gross Profit | 69.85 Million | 89.99 Million | 287.75 Million | 70.16 Million | 87.85 Million | 73.52 Million |
| Operating Expenses | 43.03 Million | 50.57 Million | 174.66 Million | 39.92 Million | 62.16 Million | 55.77 Million |
| Selling, General and Administrative Expenses | 43.03 Million | 50.57 Million | - | 39.92 Million | 45.32 Million | 38.83 Million |
| Research and Development Expenses | - | - | - | - | - | - |
| Other Expenses | 7.65 Million | 1.11 Million | 6.17 Million | 502 Thousand | 35 Thousand | 4.52 Million |
| Cost and Expenses | 295.25 Million | 346.98 Million | 1.45 Billion | 400.86 Million | 369.73 Million | 336.43 Million |
| Operating Income | 26.82 Million | 39.41 Million | 113.09 Million | 30.24 Million | 25.68 Million | 17.74 Million |
| Interest Expense | 14.35 Million | 12.32 Million | 49.15 Million | 12.74 Million | 12.98 Million | 11.09 Million |
| Income Tax Expense | 3.81 Million | 1.27 Million | 13.72 Million | 5.2 Million | 4.18 Million | 3.06 Million |
| Earnings before Tax | 20.12 Million | 27.89 Million | 69.21 Million | 17.41 Million | 12.74 Million | 11.17 Million |
| Net Income | 16.3 Million | 26.61 Million | 55.48 Million | 12.2 Million | 8.55 Million | 8.1 Million |
| Earnings Per Share Basic | 2.17 | 3.53 | - | 1.62 | 1.14 | 1.08 |
| Earnings Per Share Diluted | 2.17 | 3.53 | - | 1.62 | 1.14 | 1.08 |
| Weighted Average Shares Outstanding | 7.53 Million | 7.53 Million | 7.53 Million | 7.53 Million | 7.53 Million | 7.53 Million |
| Weighted Average Shares Outstanding (Diluted) | 7.53 Million | 7.53 Million | 7.53 Million | 7.53 Million | 7.53 Million | 7.53 Million |
| Gross Margin | 0.22 | 0.23 | 0.18 | 0.16 | 0.22 | 0.21 |
| EBIT Margin | 0.10 | 0.12 | - | 0.08 | 0.08 | 0.08 |
| Profit Margin | 0.05 | 0.07 | 0.04 | 0.03 | 0.02 | 0.02 |
| EBITDA | 32.31 Million | 44.73 Million | - | 35.19 Million | 30.66 Million | 27 Million |
| Earnings Before Tax Margin | 0.08 | 0.10 | 0.07 | 0.07 | 0.06 | 0.05 |
ALPHAIND
ALFAA
LISN
MAYNF
RIGG
UBAAF